Disposable Syringes Market Size & Share Analysis – Industry Report on Growth, Trends & Forecasts (2024 - 2029)

Market Size and Share Analysis:

By type, the safety syringes segment is projected to experience the highest growth rate at 10.01% during the forecast period. Additionally, in 2024, the hospital segment is expected to dominate the disposable syringes market, capturing 48.38% of the total share. By application, the insulin injections segment is expected to hold the major share of the market. Market analysis indicates that the size of the hospital segment is expected to reach a market value of USD 11.76 billion by 2029. As the prevalence of chronic diseases and infectious diseases continues to rise, the market is set for expansion.

The government adopts various initiatives to implement the usage of disposable syringes and reduce infection transmission. For instance, in February 2024, Kenya's immunization system strongly advocates using auto-disable (AD) syringes. These syringes are engineered to automatically lock after a single injection, thereby preventing reuse, making them the gold standard for vaccination safety. Additionally, market player initiatives such as new programs and product launches are anticipated to drive the market growth of disposable syringes. For instance, in May 2024, Hindustan Syringes and Medical Devices (HMD) introduced the groundbreaking Dispojekt Syringes with Safety Needles, marking a major advancement in the medical device field and reinforcing India's status as a global leader in this industry. With the innovative Dispojekt safety needle syringes, the company seeks to lower the incidence of accidental needle stick injuries (NSIs) among healthcare professionals, reduce infection and training costs, and ultimately create a significant positive financial impact on the healthcare sector. Similar initiatives by market players are expected to drive growth in the studied market.

Overview of Market Segments Covered:

By safety syringes, the retractable safety syringes segment is anticipated to hold the largest disposable syringes market share with USD 1.9 billion in 2024, and a CAGR of 10.52% over the forecast period (2024-2029). Retractable safety syringes are utilized for subcutaneous, intramuscular, and intravenous injections. These syringes feature a safety mechanism that automatically retracts the needle into the plunger after the injection, helping to prevent accidental needle sticks and reuse. The increasing product launches by the market players are anticipated to fuel the segment growth. For instance, in February 2024, Coherus BioSciences, Inc. launched UDENYCA ONBODY, an on-body injector (OBI) for UDENYCA (pegfilgrastim-cbqv). This innovative device is being widely distributed to accounts across the United States, allowing patients to access its benefits. The design of UDENYCA ONBODY prioritizes patient convenience, featuring a five-minute injection duration, an indicator, a status light, and an auditory signal to confirm the dosage has been delivered. After the dose is given, the needle automatically retracts to minimize the risk of needlestick injuries. Additionally, in February 2023, Zephyrus Innovations obtained its first 510(k) marketing clearance from the United States Food and Drug Administration (FDA) for its Aeroject 3ml safety syringe. This syringe features a needle system equipped with an internal mechanism that retracts the needle back into the syringe after activation. Once retracted, the needle is entirely contained within the syringe plunger, effectively preventing the reuse of both the needle and the syringe and offers protection against accidental needlestick injuries during routine handling and disposal. Such product launches and innovations by the market players are anticipated to fuel the segment's growth.

The disposable syringes market is segmented by type, end users, and application. By type, the market is segmented into conventional syringes and safety syringes. By safety syringes, the market is segmented into retractable safety syringes and non-retractable safety syringes. By end user, the market is segmented into hospitals, diagnostic laboratories, and other end-users. By application, the market is segmented into insulin injections, vaccination, chemotherapy, pain management, and other therapeutic applications. Disposable syringes are designed to be discarded after one use. Ideally, these syringes remove the necessity for sterilization since they are meant for single use, and the commercially available ones are pre-sterilized.

Regional Market Scope of this Report:

By geography, North America accounted for the largest share of 39.50% in the market analysis and is anticipated to hold a market size of USD 6.51 billion in 2024, with an anticipated CAGR of 9.87% during the forecast period. The growth of the North American disposable syringes market is attributed to several factors, including the high prevalence of various diseases, which increases the demand for diagnosis and treatment, government initiatives to prevent infectious diseases associated with the use of multi-use syringes, and the recent approval of several parenteral drugs by regulatory authorities, among other factors. For instance, in April 2023, the public syringe disposal pilot program was initiated in Dover, Delaware, United States, with the installation of two needle disposal units. This initiative seeks to tackle community concerns regarding the improper disposal of syringes in the region. Additionally, the data published by the Canadian Institute for Health Information in February 2024 reported that Canada experienced 2.96 million acute inpatient hospitalizations in 2023, an increase from the 2.88 million visits recorded in 2022. Thus, the significant number of hospital admissions in the country and government initiatives create a demand for disposable syringes for both treatment and diagnostic purposes, which is anticipated to drive North American market growth.

By geography, the global market of disposable syringes is segmented into North America (United States, Canada, Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa), and South America (Brazil, Argentina, Rest of South America). Emerging markets, especially in the Asia-Pacific region and certain areas of Africa, are experiencing a rising demand for disposable syringes. The North America and Europe regions are expected to witness significant growth in the disposable syringes industry.

Competitive Landscape and Ecosystem Analysis:

Some of the key players in the disposable syringes industry are Becton, Dickinson and Company, Terumo Corporation, Cardinal Health, Schott AG, Nipro, Gerresheimer AG, Baxter International Inc., B. Braun SE, Hindustan Syringes and Medical Devices Ltd. and Retractable Technologies, Inc., among others. The strategic initiatives by the key companies, such as the integration of disinfection units to expand the availability of products to customers, are likely to drive market growth. For instance, in May 2023, Becton, Dickinson, and Company broadened customer access to a convenient all-in-one prefilled flush syringe equipped with an integrated disinfection unit. The BD PosiFlush SafeScrub is a prefilled saline flush syringe that incorporates an active disinfection unit directly within the tip cap. The market for disposable syringes is characterized by fragmentation because of many companies operating within it. The competitive landscape involves examining several domestic and international market players that hold significant global disposable syringes market share.